Christian Sandrock, MD, MPH, FCCP

Broad-spectrum oral antibiotics play an important role in treating mixed or complicated infections, especially when both gram-positive and gram-negative coverage is needed.

Earlier discharge enabled by long-acting antibiotics must be balanced with strong follow-up and social support to ensure successful recovery.

Long-acting antibiotics have evolved from niche treatments to key tools for preventing hospital admissions and improving infection management efficiency.

Effective empiric therapy requires balancing coverage for common bacteria while considering patient stability, adherence, and potential for chronic or atypical infections.

New diagnostic tools offer limited impact in improving skin infection classification, while rapidly growing mycobacterial infections complicate diagnosis and empiric therapy.

Many skin infections are mistakenly diagnosed when noninfectious conditions like venous stasis or edema mimic infectious presentations, leading to unnecessary antibiotic use.

Christian Sandrock, MD, MPH, FCCP, shares key takeaways on the antimicrobial resistant gram-negative infection space from ID week 2023.

An infectious disease expert reviews new treatment recommendations for patients suspected of having a polymicrobial infection.

Christian Sandrock, MD, MPH, FCCP, highlights key takeaways on approaching treatment of antimicrobial resistant gram-negative infections as presented in updated IDSA guidelines and ID week 2023.

Dr Christian Sandrock evaluates the impact of 2023 updated IDSA guidelines on treatment decisions for patients with antimicrobial resistant gram-negative infections and for patients with multidrug-resistant pathogens.

Christian Sandrock, MD, MPH, FCCP, highlights key takeaways from 2023 Infectious Diseases Society of America (IDSA) updated guidelines for antimicrobial resistant gram-negative infections and how these updates have been implemented at his institution.